Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 31 n°159

Posts Tagged ‘morgan’

37th Annual J.P. Morgan Healthcare Conference

Posted by fidest press agency su giovedì, 3 gennaio 2019

San Francisco on Wednesday, January 9, 2019 Time: 11:00 a.m. PT Westin St. Francis, Elizabethan D. Merck (NYSE:MRK), Morphic Therapeutic, a biotechnology company developing a new generation of oral integrin therapies, announced today that the company will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco Praveen Tipirneni, M.D., president and CEO of Morphic, will provide an overview of the company, its innovative platform for designing integrin oral inhibitors, and anticipated milestones in 2019.Morphic is developing highly differentiated molecules for the treatment of autoimmune diseases, fibrotic diseases, and cancer. In 2018, Morphic announced the completion of a $80 million Series B financing and entered into a research and development collaboration with AbbVie designed to advance a number of Morphic’s oral integrin therapeutics for fibrosis-related indications.

Posted in Estero/world news | Contrassegnato da tag: , | Leave a Comment »

Sage Therapeutics to Present at J.P. Morgan Healthcare Conference

Posted by fidest press agency su sabato, 29 dicembre 2018

Sage Therapeutics (NASDAQ: SAGE), a clinical-stage biopharmaceutical company developing novel medicines to treat life-altering central nervous system (CNS) disorders, today announced that the Company will present at the J.P. Morgan 2019 Healthcare Conference in San Francisco, Calif. on Tuesday, January 8, 2019 at 3:30 p.m. PST (6:30 p.m. EST), followed by a Q&A session.A live webcast of the presentation can be accessed on the investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will also be archived for up to 30 days on Sage’s website following the conference.Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering CNS disorders. Sage’s lead product candidate, ZULRESSO™ (brexanolone) injection, has completed Phase 3 clinical development for postpartum depression and a New Drug Application is currently under review with the U.S. Food and Drug Administration. Sage is developing a portfolio of novel product candidates targeting critical CNS receptor systems, including SAGE-217, which is in Phase 3 development in major depressive disorder and postpartum depression. For more information, please visit http://www.sagerx.com.

Posted in Estero/world news, Uncategorized | Contrassegnato da tag: , , | Leave a Comment »

37th Annual J.P. Morgan Healthcare Conference

Posted by fidest press agency su domenica, 23 dicembre 2018

Novocure (NASDAQ: NVCR) will participate in the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 9, 2019, in San Francisco. William Doyle, Novocure’s Executive Chairman, will speak on behalf of the company and address questions from analysts. He is scheduled to present at 2:30 p.m. PST.A live audio webcast of the presentation and all presentation materials can be access from the Investor Relations page of Novocure’s website, http://www.novocure.com/investor-relations/, and will be available for replay for at least 14 days following the event.Novocure is an oncology company developing a profoundly different cancer treatment utilizing a proprietary therapy called Tumor Treating Fields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product is approved for the treatment of adult patients with glioblastoma. Novocure has ongoing or completed clinical trials investigating Tumor Treating Fields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, liver cancer and mesothelioma.Headquartered in Jersey, Novocure has U.S. operations in Portsmouth, New Hampshire, Malvern, Pennsylvania and New York City. Additionally, the company has offices in Germany, Switzerland, Japan and Israel. For additional information about the company, please visit http://www.novocure.com or follow us at http://www.twitter.com/novocure.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

37th Annual J.P. Morgan Healthcare Conference

Posted by fidest press agency su venerdì, 21 dicembre 2018

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 8, 2019 at 11:30 a.m. Pacific Time (PT). The presentation will be followed by a Q&A session at noon PT.
The presentation and Q&A session will be webcast live and may be accessed through the investors section of Hologic’s website at http://investors.hologic.com. The webcasts will be available for 30 days.
Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit http://www.hologic.com

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Medidata to Present at the 46th Annual J.P. Morgan Global Technology

Posted by fidest press agency su domenica, 13 maggio 2018

Medidata (NASDAQ:MDSO) announced that Tarek Sherif, chairman and chief executive officer, will present at the 46th Annual J.P. Morgan Global Technology, Media and Communication Conference on Wednesday, May 16, 2018, at 3:00 p.m. ET in Boston, Mass.A live audio webcast and replay will be available at http://investor.mdsol.com.
Medidata’s unified platform, pioneering analytics, and unrivaled expertise power the development of new therapies for over 1,000 pharmaceutical companies, biotech, medical device firms, academic medical centers and contract research organizations around the world. The Medidata Clinical Cloud® connects patients, physicians and life sciences professionals. Companies on the Medidata platform are individually and collaboratively reinventing the way research is done to create smarter, more precise treatments. For more information: http://www.mdsol.com

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »